Cardiff Oncology, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
CRDF on Nasdaq
Location
11055 Flintkote Avenue, San Diego, CA

Insiders trading volume in the past year

Cardiff Oncology, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gary Pace Director $5.86M +$940K +19.1% Dec 11, 2024
Mark Erlander Chief Executive Officer, Director $5.64M Mar 7, 2024
E. James Levine Chief Financial Officer $2.84M +$36.7K +1.31% Dec 16, 2024
Vicki Kelemen Exec. VP and COO $1.82M Mar 15, 2023
Tod Smeal Chief Scientific Officer $1.68M Mar 7, 2024
Fairooz Kabbinavar Chief Medical Officer $1.64M Mar 7, 2024
Thomas Adams Former Director $1.24M Jun 10, 2021
Katherine Ruffner Chief Medical Officer $962K Mar 9, 2022
Rodney Markin Director $473K Jun 27, 2024
Renee P. Tannenbaum Director $402K +$34.2K +9.31% Dec 12, 2024
James Armitage Director $382K Jun 27, 2024
Lale White Director $382K Jun 27, 2024
Mani Mohindru Director $333K Jun 27, 2024
John Brancaccio Former Director $326K Jun 9, 2022
Gary Jacob Former Director $198K Jun 10, 2021

Recent Insider Transactions by Companies or Individuals for Cardiff Oncology, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.